Genetic Test Company 23andMe Completes Merger with Richard Branson ’s VG Acquisition Corp., Stock Now Trades on NASDAQ

23andMe executives say they plan to leverage their database of millions of customer genotypes ‘to help accelerate personalized healthcare at scale,’ a key goal of precision medicine In what some financial analysts believe may be an indication that popularity of direct-to-consumer (DTC) genetic testing among customers who seek info on their ethnic background and genetic […] The post Genetic Test Company 23andMe Completes Merger with Richard Branson’s VG Acquisition Corp., Stock Now Trades on NASDAQ appeared first on Dark Daily.
Source: Dark Daily - Category: Laboratory Medicine Authors: Tags: Digital Pathology Lab and Pathology Mergers, Acquisitions, Valuations Laboratory Mergers and Acquisitions Laboratory News Laboratory Pathology Laboratory Testing Molecular Diagnostics, Genetic Testing, Whole Gene Sequencing Precision Medicin Source Type: news